World's Best Scientists 2026 revealed!
Jules L. Dienstag

Jules L. Dienstag

D-Index & Metrics

Microbiology

D-Index
97
Citations
49201
World Ranking
468
National Ranking
216

Medicine

D-Index
105
Citations
54361
World Ranking
6681
National Ranking
3530

Research.com Recognitions

  • 2014 - Fellow of the American Association for the Advancement of Science (AAAS)

Overview

Jules L. Dienstag is affiliated with Harvard University in the United States and specializes in the field of Medicine, with significant contributions to subfields such as Public Health, Environmental and Occupational Health, Epidemiology, Family Practice, Psychiatry and Mental Health, and Gender Studies.

Their research focuses on a range of topics including Innovations in Medical Education, Clinical Reasoning and Diagnostic Skills, Empathy and Medical Education, Medical Education and Admissions, Diversity and Career in Medicine, Hepatitis C virus research, and Liver Disease Diagnosis and Treatment.

Jules L. Dienstag has published multiple papers in prominent academic venues. Significant recent papers include:

  • "Hepatic gap junctions amplify alcohol liver injury by propagating cGAS-mediated IRF3 activation" (2020), Proceedings of the National Academy of Sciences
  • "The Harvard Medical School Pathways Curriculum: Reimagining Developmentally Appropriate Medical Education for Contemporary Learners" (2020), Academic Medicine
  • "Do Professionalism Lapses in Medical School Predict Problems in Residency and Clinical Practice?" (2020), Academic Medicine
  • "The Harvard Medical School Pathways curriculum: A comprehensive curricular evaluation" (2022), Medical Teacher
  • "A snapshot of underrepresented physicians 15 years after medical school" (2020), Advances in Health Sciences Education

Their frequent co-authors highlight collaborative work with Edward Krupat, Raymond T. Chung, Richard M. Schwartzstein, John L. Dalrymple, and Sara B. Fazio.

Jules L. Dienstag's research has appeared in several key publication venues, with multiple contributions to:

  • Hepatology
  • Academic Medicine
  • Proceedings of the National Academy of Sciences
  • Medical Teacher
  • Advances in Health Sciences Education

In recognition of their work, Jules L. Dienstag was named a Fellow of the American Association for the Advancement of Science (AAAS) in 2014.

Best Publications

  • An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis

    G. Kuo;Q.-L. Choo;H.J. Alter;G.L. Gitnick

  • Results of a Prospective Study of Acute Liver Failure at 17 Tertiary Care Centers in the United States

    George Ostapowicz;Robert J. Fontana;Frank V. Schioødt;Anne Larson

  • Treatment of chronic hepatitis C with recombinant interferon alfa. A multicenter randomized, controlled trial.

    Davis Gl;Balart La;Schiff Er;Lindsay K

  • Viral Hepatitis and Liver Disease

    Girish N. Vyas;Jules Dienstag;Jay H. Hoofnagle

  • Lamivudine as initial treatment for chronic hepatitis B in the United States.

    Jules L. Dienstag;Eugene R. Schiff;Teresa L. Wright;Robert P. Perrillo

  • An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis.

    Unknown

  • Adherence to combination therapy enhances sustained response in genotype-1-infected patients with chronic hepatitis C

    John G. McHutchison;Michael Manns;Keyur Patel;Thierry Poynard

  • Hepatitis B Virus Infection

    Jules L. Dienstag

  • A Preliminary Trial of Lamivudine for Chronic Hepatitis B Infection

    Jules L. Dienstag;Robert P. Perrillo;Eugene R. Schiff;Maria Bartholomew

  • Long-term safety of lamivudine treatment in patients with chronic hepatitis B.

    Anna S.F. Lok;Ching Lung Lai;Nancy Leung;Guang Bi Yao

  • A Randomized, Controlled Trial of Interferon Alfa-2b Alone and after Prednisone Withdrawal for the Treatment of Chronic Hepatitis B

    Robert P. Perrillo;Eugene R. Schiff;Gary L. Davis;Henry C. Bodenheimer

  • Histological outcome during long-term lamivudine therapy.

    Jules L. Dienstag;Robert D. Goldin;E.Jenny Heathcote;H.W.L. Hann

  • Prevalence and Clinical Correlates of YMDD Variants during Lamivudine Therapy for Patients with Chronic Hepatitis B

    Ching Lung Lai;Jules Dienstag;Eugene Schiff;Nancy W.Y. Leung

  • Incidence of Hepatocellular Carcinoma and Associated Risk Factors in Hepatitis C-Related Advanced Liver Disease

    Anna S. Lok;Leonard B. Seeff;Timothy R. Morgan;Adrian M. di Bisceglie

  • Des-γ-Carboxy Prothrombin and α-Fetoprotein as Biomarkers for the Early Detection of Hepatocellular Carcinoma

    Anna S. Lok;Richard K. Sterling;James E. Everhart;Elizabeth C. Wright

  • Non-A, non-B hepatitis. I. Recognition, epidemiology, and clinical features

    Jules L. Dienstag

  • Peginterferon alfa-2a and ribavirin in patients with chronic hepatitis C who have failed prior treatment.

    Mitchell L. Shiffman;Adrian M. Di Bisceglie;Karen L. Lindsay;Chihiro Morishima

  • Outcome of sustained virological responders with histologically advanced chronic hepatitis C

    Timothy R. Morgan;Timothy R. Morgan;Marc G. Ghany;Hae Young Kim;Kristin K. Snow

  • Intrahepatic cytotoxic T lymphocytes specific for hepatitis C virus in persons with chronic hepatitis.

    M J Koziel;D Dudley;J T Wong;J Dienstag

  • Nomenclature for antiviral‐resistant human hepatitis B virus mutations in the polymerase region

    Lieven J. Stuyver;Stephen A. Locarnini;Anna Lok;Douglas D. Richman

  • Prolonged Therapy of Advanced Chronic Hepatitis C with Low-Dose Peginterferon

    Adrian M. Di Bisceglie;Mitchell L. Shiffman;Gregory T. Everson;Karen L. Lindsay

Frequent Co-Authors

Robert H. Purcell
Robert H. Purcell National Institute of Allergy and Infectious Diseases
Timothy R. Morgan
Timothy R. Morgan California State University, Long Beach
Herbert L. Bonkovsky
Herbert L. Bonkovsky Wake Forest University
Marc G. Ghany
Marc G. Ghany National Institutes of Health
William M. Lee
William M. Lee The University of Texas Southwestern Medical Center
Adrian M. Di Bisceglie
Adrian M. Di Bisceglie Saint Louis University
Chihiro Morishima
Chihiro Morishima University of Washington
Gregory T. Everson
Gregory T. Everson University of Colorado Denver
Mitchell L. Shiffman
Mitchell L. Shiffman Bon Secours Health System
Raymond T. Chung
Raymond T. Chung Harvard University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Microbiology in the USA opens doors to diverse career options, including health-related fields that combine biology with data management and coding. Many students explore areas like medical billing and coding, where understanding biological data is crucial. For those interested in quick entry into the healthcare administration sector, the quickest medical billing and coding certificate online programs provide streamlined pathways to certification.

Another promising route is health information management, which blends healthcare knowledge with information systems. Earning a best online health information management degree cahiim accredited can enhance your qualifications and open career opportunities in managing patient records and healthcare data efficiently.

Professionals in these fields often pursue certifications that impact their earning potential. For instance, understanding how a certified professional coder salary correlates with certification status can guide career planning.

Moreover, individuals with a background in microbiology and health data can advance to roles such as health information managers. Learning about the health information management bachelor degree salary helps assess the long-term benefits of such career pathways.

Best Scientists Citing Jules L. Dienstag

Trending Scientists

Recently Published Articles